A Single-Arm Open-Label Multi-Center Study to Determine the Specificity of Flutemetamol (18F) Injection for Excluding the Presence of Brain Amyloid in Healthy Young Adult Subjects Aged 18 to 40

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2010
This article has no abstract
Epistemonikos ID: 4429425d37352a54d68ca820ccd9b57d8215e2f6
First added on: Apr 17, 2025